Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Villano

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2020
Narrative medicine applications for neuro-oncology patient identity and quality of lifeRobert B Slocum, John L Villano
Academic Medicine : Journal of the Association of American Medical Colleges|September 26, 2018
Paving the Way to More NIH Funding for Clinician-ResearchersCatherine R Garcia, John L Villano
Cancer Chemotherapy and Pharmacology|August 10, 2017
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytomaZhengqiu Zhou, Tracy A Howard, John L Villano
Cancer Chemotherapy and Pharmacology|April 9, 2013
Bevacizumab and central nervous system (CNS) hemorrhageNathalie Letarte, Linda R Bressler, John L Villano
The American Journal of the Medical Sciences|May 9, 2014
Age-specific cancer incidence rates increase through the oldest age groupsJigisha P Thakkar, Bridget J McCarthy, John L Villano
The Neurohospitalist|September 20, 2019
Intraventricular GlioblastomaCatherine R Garcia, Mauricio F Villamar, John L Villano
Neuro-Oncology|June 7, 2017
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials-impact of psychogenic non-epileptic seizuresAmy M Morrow, Rachael M Morgan, John L Villano
Journal of Neuro-Oncology|July 3, 2017
Narrative Medicine perspectives on patient identity and integrative care in neuro-oncologyRobert B Slocum, Tracy A Howard, John L Villano
Immunotargets and Therapy|May 6, 2020
Immunotherapy for Medulloblastoma: Current PerspectivesTanvir F Kabir, Charles A Kunos, John L Villano, et al.
Journal of Neuro-Oncology|March 15, 2017
Demographics, patterns of care, and survival in pediatric medulloblastomaEmily V Dressler, Therese A Dolecek, Meng Liu, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 20, 2020
Narrative medicine applications for neuro-oncology patient identity and quality of lifeRobert B Slocum, John L Villano
Academic Medicine : Journal of the Association of American Medical Colleges|September 26, 2018
Paving the Way to More NIH Funding for Clinician-ResearchersCatherine R Garcia, John L Villano
Cancer Chemotherapy and Pharmacology|August 10, 2017
Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytomaZhengqiu Zhou, Tracy A Howard, John L Villano
Cancer Chemotherapy and Pharmacology|April 9, 2013
Bevacizumab and central nervous system (CNS) hemorrhageNathalie Letarte, Linda R Bressler, John L Villano
The American Journal of the Medical Sciences|May 9, 2014
Age-specific cancer incidence rates increase through the oldest age groupsJigisha P Thakkar, Bridget J McCarthy, John L Villano
The Neurohospitalist|September 20, 2019
Intraventricular GlioblastomaCatherine R Garcia, Mauricio F Villamar, John L Villano
Neuro-Oncology|June 7, 2017
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials-impact of psychogenic non-epileptic seizuresAmy M Morrow, Rachael M Morgan, John L Villano
Journal of Neuro-Oncology|July 3, 2017
Narrative Medicine perspectives on patient identity and integrative care in neuro-oncologyRobert B Slocum, Tracy A Howard, John L Villano
Immunotargets and Therapy|May 6, 2020
Immunotherapy for Medulloblastoma: Current PerspectivesTanvir F Kabir, Charles A Kunos, John L Villano, et al.
Journal of Neuro-Oncology|March 15, 2017
Demographics, patterns of care, and survival in pediatric medulloblastomaEmily V Dressler, Therese A Dolecek, Meng Liu, et al.
Pageof 8